- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03743207
Preterm Infants May Better Tolerate Warmer Feeds (Prematurity)
November 13, 2018 updated by: Ozge Altun Koroglu, Ege University
Preterm Infants May Better Tolerate Feeds at Temperatures Closer to Freshly Expressed Breast Milk- A Randomized Controlled Trial
Feeding intolerance is frequent among preterm infants in neonatal intensive care units (NICUs).
Although there are many studies about enteral nutrition strategies and content in preterm infants, no evidence-based standards exist for the optimal milk temperature for preterm infants.
Therefore, in this study the investigators aimed to examine the effects of feeding temperature and the possible morbidities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Feeding intolerance is one of the most frequent problems among preterm infants.
These infants are fed with expressed breast milk or preterm formulas of which the temperature is not routinely measured.
In this study, the investigators aimed to examine the effects of feeds with warm versus room temperature milk in preterm infants.
Infants with a birth weight of ≤1500 g or gestational age of ≤ 34 weeks were included in the study and assigned to two different feeding temperature groups (22-24°C and 32-34°C).
Some infants in both groups were exclusive breast milk fed and some received artificial milk.
Feeding tolerance of patients in both groups and the consequences were evaluated.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İzmir, Turkey
- Ege University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 1 month (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Infants born to birth weight of ≤1500 g
- Infants born to gestational age of ≤ 34 weeks
Exclusion Criteria:
- Genetic syndrome
- Gastrointestinal system anomalies
- Patients born small for their gestational age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Room temperature
All of the infants in neonatal intensive care units are used to be fed with milk at 22-24°C which is close to room temperature.
|
These infants were fed with room temperature (22-24 °C) so that hypothesizing that they will have more feeding tolerance and therefore more co-existing morbidities.
|
Experimental: Warmer temperature
The investigators decided to feed the infants in this group with warmer milk at to examine the effects of feeding temperature.
|
Fifteen NICU mothers volunteered and expressed their milk for rapid measurement of freshly expressed breast milk.
The mean (± SD) temperature of freshly expressed breast milk was found to be 33±1.5 °C in these preliminary measurements.
Confirming this finding, the investigators decided to feed these infants with milk at 32 - 34 °C to examine the effects of feeding temperature and the possible comorbidities with a hypothesis that warmer feeding at the temperature of freshly expressed breast milk may be better physiologically.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric residual volume in mililitres after every feeding
Time Frame: through study completion, an average of 6 months
|
Gastric residual volume amount during the study
|
through study completion, an average of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Transition time to total enteral feeding
Time Frame: through study completion, an average of 6 months
|
The time needed for transition time to total enteral feeding
|
through study completion, an average of 6 months
|
Daily weight gain
Time Frame: through study completion, an average of 6 months
|
The daily weight gain of the infant during the study
|
through study completion, an average of 6 months
|
Need for anti reflux treatment
Time Frame: through study completion, an average of 6 months
|
ıf the infant needed antireflux treatment, the treatment options were recorded
|
through study completion, an average of 6 months
|
Body weight at discharge
Time Frame: through study completion, an average of 6 months
|
Body weight at discharge
|
through study completion, an average of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ozge Altun Koroglu, M.D., Ege University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2012
Primary Completion (Actual)
April 30, 2014
Study Completion (Actual)
April 30, 2014
Study Registration Dates
First Submitted
October 30, 2018
First Submitted That Met QC Criteria
November 13, 2018
First Posted (Actual)
November 16, 2018
Study Record Updates
Last Update Posted (Actual)
November 16, 2018
Last Update Submitted That Met QC Criteria
November 13, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EGE20121284
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity
-
Stanford UniversityMedtronic - MITGCompletedIntraventricular Hemorrhage of Prematurity | Complications of PrematurityUnited States
-
Universidade Federal do MaranhãoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)CompletedExtreme PrematurityUnited States
-
University of Kansas Medical CenterCompletedComplication of PrematurityUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownPrematurity of FetusTurkey
-
Guilherme Sant'Anna, MDCompleted
-
Mansoura University Children HospitalCompletedPrematurity, Mechanical VentilationEgypt
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; German Federal Ministry of Education and Research; Société des Produits Nestlé (SPN)CompletedPrematurity of FetusGermany
-
Nantes University HospitalCompletedPrematurity and Feeding IntoleranceFrance
Clinical Trials on Room temperature
-
Karolinska InstitutetDanderyd Hospital; Stockholm South General HospitalWithdrawnSepsis | Critical Illness | Fluid Overload | Hemodynamic InstabilitySweden
-
University of ManitobaOrthopedic Research and Education Foundation; Orthopedic Trauma AssociationTerminatedProximal Tibia FractureCanada
-
Hallym University Kangnam Sacred Heart HospitalUnknownNasotracheal IntubationKorea, Republic of
-
Begona Martinez de TejadaRecruitingInduction of Labor | Unfavorable Cervix | Cervical Ripening | Mechanical MethodSwitzerland
-
Wolfson Medical CenterCompleted
-
Sahlgrenska University Hospital, SwedenKarolinska University Hospital; Uppsala University HospitalCompletedChronic Subdural HematomaSweden
-
Chulalongkorn UniversityCompletedAllergic RhinitisThailand
-
University of Texas Southwestern Medical CenterParkland Health and Hospital SystemCompletedCesarean Section | Hypothermia | Neonatal OutcomeUnited States
-
Women and Infants Hospital of Rhode IslandFoundation for Society of Maternal-Fetal MedicineRecruiting
-
Brooke Army Medical CenterCompleted